Search results for: Pricing and Reimbursement
Filter search results
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…Limits to Substitution Between Ecosystem Services and Manufactured Goods and Implications for Social Discounting. Environmental and Resource Economics, 69(1), pp.135–158. 10.1007/s10640-016-0068-5. Freeman, M., Groom, B. and Spackman, M., 2018. Social…
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
…the multiple stakeholders and intermediaries involved in pricing and formulary listing. Therefore, without wider health system reform, there is great uncertainty about how domestic pricing reform will be enacted and…
Spotlight on OHE: Value Based Pricing and New Technologies
31 December 2012
…presentation (see below) discussed methods and processes for coordinating the assessment of diagnostics and treatments and urged that a consistent approach be developed and implemented. This was based in part…
Payment Models for Multi-Indication Therapies
1 November 2021
…Available from https://www.ohe.org/publications/multi-indication-pricing-mip-practical-solutions-and-steps-move-forward. Towse, A., Cole, A., and Zamora, B. (2018) The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. OHE Consulting Report. Available from https://www.ohe.org/publications/debate-indication-based-pricing-us-and-five-major-european-countries….
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
2 June 2023
…consider i) pricing and reimbursement mechanisms, ii) standardising testing and care pathways, and iii) developing new infrastructure Share this: Download publication Next-generation sequencing (NGS) generates comprehensive and actionable information on…
New research reveals, in carers’ own words, the multidimensional burden of caring for leukemia patients
20 November 2025
…and US, and 5 each from France, Germany, Italy and Spain – were asked questions about the patient’s diagnosis and how they became a carer, their experience of caregiving as…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…discussed innovative study designs and analysis methods, critical challenges regarding heterogeneity and uncertainty from the perspective of health economics and HTA. He noted the emergence of new and innovative study…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…vaccines to middle and low income countries; and price determination that is not value-driven. We argue for a demand-side approach. By pooling commitments and pre-agreeing vaccination priorities, countries avoid destructive…
Report calls for investment in medical simulation to improve health and growth
21 October 2026
…for Health and Care Excellence (NICE) and the Health Research Authority (HRA). A further 85 national and international organisations from academia, industry, and regulation are taking part. UK CEiRSI’s aim…